When it comes to drug development timelines, the choice of formulation is key. Formulation problems can lead to lengthy and costly development delays and may even jeopardize your entire program. By the same token, precise and expert formulation development and manufacturing can be a contributing factor in whether a drug safely delivers the anticipated dosage and completes clinical trials in a timely manner.

 In this playbook, you’ll learn how liquid-filled hard-shell capsules (LFCs) can help accelerate drug development programs by providing simpler, more rapid entry to the clinic and the ability to handle dosage adjustments on the fly. Discover how embracing LFCs can lead to:

• Easier scale-up of manufacturing for late-stage trials and commercialization
• Improved applications for APIs that are poorly soluble, low-dose and/or highly potent, as well as APIs requiring sustained release and/or highly stable environments
• Customization options and new marketing opportunities

​